Denis Guttridge

Title: Denis Guttridge: Innovator in Cancer Treatment

Introduction

Denis Guttridge is a notable inventor based in Upper Arlington, OH (US). He has made significant contributions to the field of cancer treatment, particularly in addressing cancer-related cachexia. With a total of 2 patents, his work focuses on innovative methods to improve the quality of life for cancer patients.

Latest Patents

Guttridge's latest patents include "Methods for suppressing cancer-related cachexia" and "Compositions and methods for treating cachexia." The first patent provides methods for administering HDAC inhibitors to maintain a mammal's weight during cancer treatment. The second patent outlines methods for treating cachexia by inhibiting specific microRNAs and other cellular activities associated with cancer. These inventions represent a significant advancement in the management of cachexia, a debilitating condition often faced by cancer patients.

Career Highlights

Throughout his career, Denis Guttridge has worked with the Ohio State Innovation Foundation, contributing to various research initiatives aimed at improving cancer therapies. His dedication to innovation in this field has positioned him as a key figure in cancer research.

Collaborations

Guttridge has collaborated with esteemed colleagues such as Ching-Shih Chen and Tanios Bekaii-Saab. These partnerships have further enhanced his research and development efforts in cancer treatment.

Conclusion

Denis Guttridge's innovative work in cancer treatment through his patents and collaborations highlights his commitment to improving patient outcomes. His contributions to the field of cancer-related cachexia are invaluable and continue to inspire further research and development.